Alpha Tau Medical Ltd
DRTS
NASDAQ
Healthcare
$13.23
+4.67%gain today
Market position
Market cap rank
#2481
of 2,614
1-day
+4.67%
1-month
+48.15%
6-month
+167.27%
YTD
+173.91%
1-year
+317.35%
5-year
+37.10%
Key figures
Market cap
$1.2B
P/E (live)
—
price ÷ annual EPS
P/E (reported)
-9.3
FY 2025
EPS
-$0.53
FY 2025
Dividend yield
0.00%
FY 2025
Dividend / share
$0.00
Gross margin
0.00%
FY 2025
Operating margin
0.00%
FY 2025
Net margin
0.00%
FY 2025
Return on equity
—
FY 2025
Valuation & financial health
Enterprise value
$396.63M
FY 2025
EV / EBITDA
-9.66
FY 2025
EV / Sales
0.00
FY 2025
Price / book
5.17
FY 2025
Price / sales
0.00
FY 2025
Earnings yield
-10.69%
FY 2025
FCF yield
-8.21%
FY 2025
Debt / equity
0.18
FY 2025
Current ratio
7.45
FY 2025
Return on assets
—
FY 2025
Return on invested capital
Financials · FY 2025
Revenue
$0
Gross profit
$-1.23M
Operating income
$-42.29M
EBITDA
$-41.06M
Net income
$-42.63M
Diluted EPS
-$0.53
Shares outstanding
80,581,440
Trading
Open
$12.85
Previous close
$12.64
Day range
$12.39 – $13.23
52-week range
$2.87 – $13.23
50-day avg
$9.67
200-day avg
$6.67
Volume
1,149,408
Avg volume
821,624
Beta
1.17
Price history
+317.35% over 1Y
Compare with peers
About Alpha Tau Medical Ltd
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company is headquartered in Jerusalem, Israel.
Visit websiteCompany info
CEO
Uzi Sofer
IPO date
Mar 8, 2021
Headquarters
Jerusalem, IL
Country
IL
Fundamentals are annual. Figures labeled with their fiscal year.
